161 related articles for article (PubMed ID: 16949126)
1. Mechanistic differences between in vitro assays for hydrazone-based small molecule inhibitors of anthrax lethal factor.
Hanna ML; Tarasow TM; Perkins J
Bioorg Chem; 2007 Feb; 35(1):50-8. PubMed ID: 16949126
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of the proteolytic activity of anthrax lethal factor by aminoglycosides.
Lee LV; Bower KE; Liang FS; Shi J; Wu D; Sucheck SJ; Vogt PK; Wong CH
J Am Chem Soc; 2004 Apr; 126(15):4774-5. PubMed ID: 15080670
[TBL] [Abstract][Full Text] [Related]
3. The anthrax lethal factor and its MAPK kinase-specific metalloprotease activity.
Tonello F; Montecucco C
Mol Aspects Med; 2009 Dec; 30(6):431-8. PubMed ID: 19665472
[TBL] [Abstract][Full Text] [Related]
4. Proteolytic assay-based screening identifies a potent inhibitor of anthrax lethal factor.
Park HC; Sung SR; Lim SM; Lee JS; Kim SK; Yoon MY
Microb Pathog; 2012 Aug; 53(2):109-12. PubMed ID: 22561400
[TBL] [Abstract][Full Text] [Related]
5. Selectively guanidinylated derivatives of neamine. Syntheses and inhibition of anthrax lethal factor protease.
Jiao GS; Simo O; Nagata M; O'Malley S; Hemscheidt T; Cregar L; Millis SZ; Goldman ME; Tang C
Bioorg Med Chem Lett; 2006 Oct; 16(19):5183-9. PubMed ID: 16870442
[TBL] [Abstract][Full Text] [Related]
6. Guanidinylated 2,5-dideoxystreptamine derivatives as anthrax lethal factor inhibitors.
Jiao GS; Cregar L; Goldman ME; Millis SZ; Tang C
Bioorg Med Chem Lett; 2006 Mar; 16(6):1527-31. PubMed ID: 16386899
[TBL] [Abstract][Full Text] [Related]
7. Novel small-molecule inhibitors of anthrax lethal factor identified by high-throughput screening.
Schepetkin IA; Khlebnikov AI; Kirpotina LN; Quinn MT
J Med Chem; 2006 Aug; 49(17):5232-44. PubMed ID: 16913712
[TBL] [Abstract][Full Text] [Related]
8. Probing the S2' Subsite of the Anthrax Toxin Lethal Factor Using Novel N-Alkylated Hydroxamates.
Kurbanov EK; Chiu TL; Solberg J; Francis S; Maize KM; Fernandez J; Johnson RL; Hawkinson JE; Walters MA; Finzel BC; Amin EA
J Med Chem; 2015 Nov; 58(21):8723-33. PubMed ID: 26492514
[TBL] [Abstract][Full Text] [Related]
9. Computational insights into the interaction of the anthrax lethal factor with the N-terminal region of its substrates.
Joshi M; Ebalunode JO; Briggs JM
Proteins; 2009 May; 75(2):323-35. PubMed ID: 18831046
[TBL] [Abstract][Full Text] [Related]
10. Screening inhibitors of anthrax lethal factor.
Tonello F; Seveso M; Marin O; Mock M; Montecucco C
Nature; 2002 Jul; 418(6896):386. PubMed ID: 12140548
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of the anthrax lethal factor.
Pannifer AD; Wong TY; Schwarzenbacher R; Renatus M; Petosa C; Bienkowska J; Lacy DB; Collier RJ; Park S; Leppla SH; Hanna P; Liddington RC
Nature; 2001 Nov; 414(6860):229-33. PubMed ID: 11700563
[TBL] [Abstract][Full Text] [Related]
12. Anthrax lethal factor inhibitors as potential countermeasure of the infection.
Kumar BV; Malik S; Grandhi P; Dayam R; Sarma JA
Curr Top Med Chem; 2014; 14(17):1977-89. PubMed ID: 25262802
[TBL] [Abstract][Full Text] [Related]
13. Stop the killer: how to inhibit the anthrax lethal factor metalloprotease.
Montecucco C; Tonello F; Zanotti G
Trends Biochem Sci; 2004 Jun; 29(6):282-5. PubMed ID: 15276179
[TBL] [Abstract][Full Text] [Related]
14. Low molecular weight inhibitors of the protease anthrax lethal factor.
Dalkas GA; Papakyriakou A; Vlamis-Gardikas A; Spyroulias GA
Mini Rev Med Chem; 2008 Mar; 8(3):290-306. PubMed ID: 18336349
[TBL] [Abstract][Full Text] [Related]
15. Yeast-hybrid based high-throughput assay for identification of anthrax lethal factor inhibitors.
Kim J; Park HC; Gedi V; Park HY; Roberts AG; Atkins WM; Yoon MY
Biochem Biophys Res Commun; 2011 Jan; 404(1):517-22. PubMed ID: 21144836
[TBL] [Abstract][Full Text] [Related]
16. Mixed-type noncompetitive inhibition of anthrax lethal factor protease by aminoglycosides.
Kuzmic P; Cregar L; Millis SZ; Goldman M
FEBS J; 2006 Jul; 273(13):3054-62. PubMed ID: 16817854
[TBL] [Abstract][Full Text] [Related]
17. Structural biology: anthrax hijacks host receptor.
Bann JG; Hultgren SJ
Nature; 2004 Aug; 430(7002):843-4. PubMed ID: 15318206
[No Abstract] [Full Text] [Related]
18. Insights into the anthrax lethal factor-substrate interaction and selectivity using docking and molecular dynamics simulations.
Dalkas GA; Papakyriakou A; Vlamis-Gardikas A; Spyroulias GA
Protein Sci; 2009 Aug; 18(8):1774-85. PubMed ID: 19585464
[TBL] [Abstract][Full Text] [Related]
19. Development of a cell-based fluorescence resonance energy transfer reporter for Bacillus anthracis lethal factor protease.
Kimura RH; Steenblock ER; Camarero JA
Anal Biochem; 2007 Oct; 369(1):60-70. PubMed ID: 17586456
[TBL] [Abstract][Full Text] [Related]
20. Identification of novel anthrax lethal factor inhibitors generated by combinatorial Pictet-Spengler reaction followed by screening in situ.
Numa MM; Lee LV; Hsu CC; Bower KE; Wong CH
Chembiochem; 2005 Jun; 6(6):1002-6. PubMed ID: 15880659
[No Abstract] [Full Text] [Related]
[Next] [New Search]
